Skip to main content
RecallFDAfda-F-0090-2017OTHER

Byron J. Richards Wellness resources Hyaluronic Acid Dietary Supplement, 60 Capsules, Distributed by Wellness Resources, Inc. 7155 Amunds...

Category
Units Affected
0
Recall Date
October 10, 2014
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0090-2017.

Triceutical Inc. has recalled all dietary supplements due to lack of good manufacturing practices.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0090-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Triceutical Inc./zhang or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0090-2017.

Triceutical Inc./Zhang

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Triceutical Inc./zhang Recall FAQ

Triceutical Inc./zhang is the subject of a supplements safety report: Byron J. Richards Wellness resources Hyaluronic Acid Dietary Supplement, 60 Capsules, Distributed by Wellness Resources, Inc. 7155 Amunds.... The notice was published on October 10, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 0 units are potentially affected.